Arbutus Biopharma Statistics
NASDAQ: ABUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.29-0.19 (-4.24%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 4.35 +1.44%
Arbutus Biopharma by the numbers
Arbutus Biopharma has a market capitalization of $657.6 million based on 153.28M shares outstanding. Its trailing P/E ratio is 5.4. The stock trades 11.4% below its 50-day average and 5.5% below its 200-day average.
Average daily trading volume is 4.65M shares, or about $20.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ABUS valuation vs. peer median
| Metric | ABUS | Peer median | Difference |
|---|---|---|---|
| Market cap | $657.55M | $887.60M | -26% |
| Avg. volume | 4.65M | 753.51K | +518% |
Peer median across 8 companies: CYRX, ALMS, RIGL, JBIO, CRVS, ANL, MLTX, ANRO.
Valuation
- Market cap
- $657.55M
- P/E (TTM)
- 5.43
- EPS (TTM)
- $0.79
- Shares outstanding
- 153.28M
Price and trading
- Previous close
- 4.48
- Open
- 4.46
- Day range
- 4.28 – 4.48
- 52-week range
- 3.50 – 5.45
- 52-week change
- 0.00%
- Beta
- —
- Volume
- 4.79M
- Average volume
- 4.65M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 657.55M
- Pe
- 5.43
- Forward Pe
- -25.96
- Eps
- 0.79
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.45
- Week52 Low
- 3.50
- Avg Volume
- 4.65M
- Shares Outstanding
- 153.28M
- Ma50
- 4.84
- Ma200
- 4.54
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -21.28%
- Pct From52w Low
- 22.57%